Ismail Erturk — Author Profile – International Journal of Medical Science and Clinical Invention
ISSN (Online): 2348-991X | ISSN (Print): 2454-9576
IE

Ismail Erturk

Department of Internal Medicine, University of Health Sciences, Gulhane Education and Research Hospital, Ankara, Turkey,
9
Publications
1
Journals
2018
Active
Impact & Metrics
Share Share
3,537
Total Views
1,098
Downloads
0
Citations
9
Publications
Publications 9
1.
Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin
International Journal of Medical Science and Clinical Invention Vol. 5, No. 11 (2018) pp. 4157-4161 Nov 2018 10.18535/ijmsci/v5i11.04
2.
Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin
International Journal of Medical Science and Clinical Invention Vol. 5, No. 11 (2018) pp. 4157-4161 Nov 2018 10.18535/ijmsci/v5i11.04
3.
Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin
International Journal of Medical Science and Clinical Invention Vol. 5, No. 11 (2018) pp. 4157-4161 Nov 2018 10.18535/ijmsci/v5i11.04
4.
Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin
International Journal of Medical Science and Clinical Invention Vol. 5, No. 11 (2018) pp. 4157-4161 Nov 2018 10.18535/ijmsci/v5i11.04
5.
Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin
International Journal of Medical Science and Clinical Invention Vol. 5, No. 11 (2018) pp. 4157-4161 Nov 2018 10.18535/ijmsci/v5i11.04
6.
Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin
International Journal of Medical Science and Clinical Invention Vol. 5, No. 11 (2018) pp. 4157-4161 Nov 2018 10.18535/ijmsci/v5i11.04
7.
Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin
International Journal of Medical Science and Clinical Invention Vol. 5, No. 11 (2018) pp. 4157-4161 Nov 2018 10.18535/ijmsci/v5i11.04
8.
Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin
International Journal of Medical Science and Clinical Invention Vol. 5, No. 11 (2018) pp. 4157-4161 Nov 2018 10.18535/ijmsci/v5i11.04
9.
Evaluation of the effects of various treatment modalities on angiogenesis in heart failure with reduced ejection fraction and heart failure mid-range ejection fraction patients without chronic kidney disease via angiostatin
International Journal of Medical Science and Clinical Invention Vol. 5, No. 11 (2018) pp. 4157-4161 Nov 2018 10.18535/ijmsci/v5i11.04
Author Resources
Journal Policies
Author Desk